Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity includes developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invested in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The Company's portfolio consists of pharmaceutical products with molecules and includes both in-licensed products, such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome as well as products owned (or partially owned) by it, such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by longrun86on Oct 06, 2022 12:55am
186 Views
Post# 35008501

RE:RE:25k shares jump to 316k at 11:15 osh

RE:RE:25k shares jump to 316k at 11:15 oshThe past few months have been pretty boring but I've been ok with it.

I would like to think that at these prices the shares are going to stronger hands. The Company itself is likely one of the strongest hands in the market with the weakest not being apathetic individual shareholders but rather ETF's which often appear agnostic to valuation.

I've been watching the situation play out in Brazil which will be interesting to see how the run-off plays out. Argentina is the mess we all know it to be. Chileans have rejected the madness of a new constitution. Columbia is keepin' on. The US appears to understand it has a role to play in South America. Ultimately, people need medicine and South America is a tough market for Pharma companies to navigate.


<< Previous
Bullboard Posts
Next >>